Navigation Links
Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal
Date:8/13/2008

FORT WORTH, Texas, Aug. 13 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), is excited about expanding upon the announcement that was made on Tuesday regarding the publication of (2) independent case reports utilizing their advanced wound care collagen product, CellerateRx(R), in the August edition of Advances in Skin and Wound Care. The case presentations were on recalcitrant diabetic wounds. The article will be available in its entirety for viewing on the company website, http://www.celleraterx.com in two weeks. In the meantime, the abstract may be viewed by going to http://www.woundcarejournal.com, click current issue (top left corner), then scroll down to article 370 "Activated, Type I Collagen (CellerateRx) and Its Effectiveness in Healing Recalcitrant Diabetic Wounds: A Case Presentation" and click abstract.

"We are excited about providing additional data regarding the cases that have successfully identified CellerateRx(R) as a very strong product in the management of diabetic wounds. We are also very excited about being able to provide eprints of the article on our site in the near term to enable our shareholders and customers to have the most up-to-date information on CellerateRx(R)," states Cathy Bradshaw, President of Wound Care Innovations, LLC.

Please feel free to contact us with any additional questions on the product or the development of our Company.

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at http://www.Celleraterx.com.

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

Product Information Shareholder Relations

Cathy Bradshaw Lucy Singleton

President Secretary

954-315-9242 817-820-7080


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
2. Michael and Terry Ward Donate $1 Million to Wounded Warrior Project (WWP)
3. Canica Design Awarded Milestone U.S. Patent for Dynamic Wound Closure Systems
4. Wound Management Technologies, Inc. Announces Filing of a 510K
5. ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business
6. The Wound Institute(R) Launches Educational Course on Chronic Wound Infections
7. Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc.
8. Freedom Celebration - Gibson Guitar to Provide Instruments for the Wounded
9. National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers
10. Wound Care Education Institute to Partner with Wisconsin Organizations to Improve Pressure Ulcer Care
11. Antibiotics can prevent wound complications of childbirth, Stanford/Packard study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... ... Goodcents Deli Fresh Subs announced a franchise expansion agreement today including three ... The first new location will open at the corner of 27th and Randolph in ... Drive this fall. And the third location is in the process of being identified. ...
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in the ... water-related accidents and drownings during the summer. While most of us assume this type ... occur every day. Very few people are taking the time to learn how to ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... management in hospitals, today announced it has completed a round of funding to ... LLC and its partners. Black Granite Capital is a growth equity firm focused ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... Journal ... adults. It can have severe consequences to overall dental health, including complications with speech, ... often turn to dental implants to replace lost teeth. As the number of tooth ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... the adoption of e-prescribing as measured in Part D Medicare data. The dataset, ... to pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology: